Evogene (EVGN) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Evogene’s subsidiary, Lavie Bio, faces a strategic shift as Corteva Agriscience terminates their licensing agreement for bio-fungicide candidates. Despite this setback, Lavie Bio will retain rights to the technology and plans to advance its bio-fungicide pipeline independently. Other collaborations between Lavie Bio and Corteva remain unaffected.
For further insights into EVGN stock, check out TipRanks’ Stock Analysis page.
